FERRARINI, Isacco
 Distribuzione geografica
Continente #
NA - Nord America 1.311
EU - Europa 1.092
AS - Asia 968
SA - Sud America 147
AF - Africa 28
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.554
Nazione #
US - Stati Uniti d'America 1.285
SG - Singapore 390
CN - Cina 273
DE - Germania 192
IT - Italia 191
GB - Regno Unito 158
HK - Hong Kong 146
BR - Brasile 111
RU - Federazione Russa 101
FI - Finlandia 94
FR - Francia 93
IE - Irlanda 84
SE - Svezia 84
VN - Vietnam 49
KR - Corea 37
NL - Olanda 26
ID - Indonesia 21
AT - Austria 16
CA - Canada 15
ES - Italia 13
IN - India 12
TG - Togo 10
UA - Ucraina 10
AR - Argentina 9
BD - Bangladesh 7
MX - Messico 7
PL - Polonia 7
AU - Australia 6
CL - Cile 6
JP - Giappone 6
SC - Seychelles 6
TR - Turchia 6
BE - Belgio 5
CO - Colombia 5
PE - Perù 5
PT - Portogallo 5
IQ - Iraq 4
MA - Marocco 4
PY - Paraguay 4
ZA - Sudafrica 4
EC - Ecuador 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IR - Iran 2
JM - Giamaica 2
PS - Palestinian Territory 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LT - Lituania 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.554
Città #
Dallas 412
Singapore 185
Chandler 165
Hong Kong 146
Southend 133
Munich 120
Dublin 78
Ashburn 72
Beijing 66
Helsinki 65
Jacksonville 42
Verona 39
Lawrence 28
Princeton 28
Woodbridge 26
The Dalles 25
Columbus 20
Jinan 20
Jakarta 19
Los Angeles 19
Milan 19
Wilmington 19
Nanjing 16
New York 16
Santa Clara 16
Ann Arbor 15
Redmond 15
Shenyang 13
Sindelfingen 13
Council Bluffs 12
Houston 12
Seattle 12
Zhengzhou 12
Frankfurt am Main 11
Ho Chi Minh City 11
Turku 11
Lomé 10
Nuremberg 10
Vienna 10
Changsha 9
Dong Ket 9
Fairfield 9
Amsterdam 8
Hebei 8
Lappeenranta 8
Bologna 7
Brooklyn 7
San Francisco 7
Seoul 7
Tianjin 7
Toronto 7
Vicenza 7
Guangzhou 6
Hanoi 6
Mahé 6
Redwood City 6
São Paulo 6
Trento 6
Washington 6
Barcelona 5
Haikou 5
Hangzhou 5
Madrid 5
Nanchang 5
Rio de Janeiro 5
Taizhou 5
Warsaw 5
Arezzo 4
Boardman 4
Brussels 4
Buffalo 4
Cagliari 4
Chicago 4
Jiaxing 4
Kent 4
Lanzhou 4
Leawood 4
Montichiari 4
Moscow 4
Ningbo 4
Roubaix 4
Shijiazhuang 4
Stockholm 4
Tokyo 4
Atlanta 3
Bogotá 3
Brasília 3
Dearborn 3
Jyväskylä 3
Lima 3
Lisbon 3
London 3
Melbourne 3
Montreal 3
Norwalk 3
Padua 3
Phoenix 3
Poncarale 3
Porto Alegre 3
Rome 3
Totale 2.259
Nome #
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 171
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 149
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 148
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 144
Synthetic PGI-2 (Iloprost) treatment in patients with resistant sclerodermic chronic GVHD (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation 124
Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells 123
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase 110
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 109
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes 102
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 96
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 96
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study 95
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 91
IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES 88
Monocyte-to-macrophage switch reversibly impaired by Ibrutinib. 86
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review 86
West Nile Virus Encephalitis in Haematological Setting: Report of Two Cases and a Brief Review of the Literature 85
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma 84
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level 84
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. 83
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 80
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 79
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia 78
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 78
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 76
ONC212 IS A NOVEL MITOCAN ACTING SYNERGISTICALLY WITH GLYCOLYSIS INHIBITION IN PANCREATIC CANCER 73
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine 71
The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment 57
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 57
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma 55
Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis 55
Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma 55
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome 53
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer 53
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study 47
Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients 45
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey 41
A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma 40
Extracellular Vesicles based STAT3 delivery as innovative therapeutic approach to restore STAT3 signaling deficiency 40
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper 40
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 39
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 38
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy 38
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report 38
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma 36
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 34
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 23
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population 22
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia 20
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 17
Totale 3.632
Categoria #
all - tutte 15.715
article - articoli 15.189
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 526
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 7 21 19 30 0 6 8 5 14 19
2021/2022219 12 50 2 10 35 4 7 12 4 14 12 57
2022/2023500 30 67 37 92 38 112 11 36 57 6 7 7
2023/2024327 11 30 49 34 25 41 20 26 9 20 49 13
2024/20251.268 46 49 72 180 55 84 84 86 184 83 124 221
2025/2026810 216 393 201 0 0 0 0 0 0 0 0 0
Totale 3.632